Hyperfine (NASDAQ:HYPR) Shares Up 1.5% – Still a Buy?

Hyperfine, Inc. (NASDAQ:HYPR) shares traded up 1.5% during trading on Thursday . The stock traded as high as $1.02 and last traded at $1.01. 62,037 shares traded hands during mid-day trading, a decline of 38% from the average session volume of 100,791 shares. The stock had previously closed at $1.00.

Hyperfine Stock Performance

The company has a 50-day simple moving average of $0.97 and a two-hundred day simple moving average of $1.00. The firm has a market capitalization of $72.95 million, a P/E ratio of -1.75 and a beta of 0.86.

Hyperfine (NASDAQ:HYPR) last released its earnings results on Tuesday, November 12th. The company reported ($0.14) EPS for the quarter, meeting analysts’ consensus estimates of ($0.14). The company had revenue of $3.64 million during the quarter, compared to analysts’ expectations of $3.40 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same quarter last year, the business posted ($0.15) EPS. As a group, research analysts forecast that Hyperfine, Inc. will post -0.57 earnings per share for the current fiscal year.

Institutional Trading of Hyperfine

An institutional investor recently raised its position in Hyperfine stock. Geode Capital Management LLC increased its holdings in shares of Hyperfine, Inc. (NASDAQ:HYPR) by 18.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 624,520 shares of the company’s stock after acquiring an additional 98,335 shares during the period. Geode Capital Management LLC owned approximately 0.86% of Hyperfine worth $675,000 at the end of the most recent reporting period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.